CorMedix CRMD Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $38.6M+175% | $14.02M-87.1% | $108.56M+448% | $19.83M-4.0% | $20.64M— | ||
| $10.54M+3,485% | $294.1K+81.6% | $161.92K+174% | $58.99K-63.6% | $162K+98.1% | ||
| $4.58M+27.7% | $3.59M-11.7% | $4.07M+51.9% | $2.68M-23.5% | $3.5M+193% | ||
| $12.96M— | —— | -$59.7M-11,548% | $521.51K— | $0— | ||
| —— | $99.5K0.0% | $99.5K0.0% | $99.5K0.0% | $99.5K— | ||
| -$16.45M-233% | $12.4M-85.8% | $87.27M+845% | -$11.71M-495% | $2.97M-91.4% | ||
| $1.02M+26.9% | $800.12K+24.4% | $642.98K-70.1% | $2.15M+2,017% | -$112K-112% | ||
| $4.94M— | —— | $6.5M+67.4% | $3.88M+1,723% | $213K— | ||
| -$50.62M-197% | $52.28M-4.5% | $54.73M+938% | -$6.53M-2,337% | $292K-98.1% | ||
| $2.26M+65.5% | $1.36M— | —— | —— | $2.27M+314% | ||
| -$672K-285% | $363.23K— | —— | —— | -$46K-18,399,999,900% | ||
| $42.38M-55.1% | $94.46M+206% | $30.86M+2.9% | $29.99M+52.0% | $19.74M+452% | ||
| $729K-57.6% | $1.72M+240% | $505.77K+1,997% | $24.12K+141% | $10K-1.4% | ||
| $0-100% | $1.25M0.0% | $1.25M-95.6% | $28.29M+183% | $9.99M+88.6% | ||
| $3.69M+2.6% | $3.6M-89.3% | $33.79M+317% | $8.1M-17.3% | $9.8M+96.0% | ||
| $2.97M— | $0+100% | -$291.32M-1,341% | -$20.21M-10,265% | -$195K— | ||
| $11.09M— | —— | —— | —— | $0— | ||
| $0-100% | $1.03M— | —— | —— | $6.76M+22.8% | ||
| $1.53M+493% | $257.44K-44.5% | $464.09K+87.5% | $247.47K-75.7% | $1.02M+1,809% | ||
| $522K— | —— | —— | —— | $0— | ||
| $135K-2.7% | $138.81K+182% | $49.19K— | $0— | $0— | ||
| -$12.1M— | $0-100% | $150.53M+80.8% | $83.24M+1,266% | $6.09M-46.0% | ||
| $0— | —— | $276-73.9% | $1.06K— | $0+100% | ||
| $33.25M-65.5% | $96.34M— | —— | $93.02M+263% | $25.64M— | ||
| $2.82M+877,470% | $321— | $0-100% | $6.68K-33.2% | $10K+4.1% | ||
| —— | $4.5K0.0% | $4.5K0.0% | $4.5K0.0% | $4.5K— | ||
| —— | $99.5K0.0% | $99.5K0.0% | $99.5K0.0% | $99.5K— | ||
| —— | $1.63M0.0% | $1.63M0.0% | $1.63M0.0% | $1.63M— | ||
| -$4.2M-2.4% | -$4.1M— | —— | —— | $0— | ||
| —— | -$25K0.0% | -$25K0.0% | -$25K0.0% | -$25K— | ||
| —— | $21.5K0.0% | $21.5K0.0% | $21.5K0.0% | $21.5K— | ||
| $2.26M+65.5% | $1.36M— | —— | —— | $2.27M+314% | ||
| -$672K-967% | -$63K0.0% | -$63K0.0% | -$63K-37.0% | -$46K-34.3% | ||
| $220K— | —— | —— | —— | $0— | ||
| $0-100% | $73.94K-99.2% | $9.61M-66.0% | $28.29M+183% | $9.99M+88.6% | ||
| $3.69M+2.6% | $3.6M-89.3% | $33.79M+317% | $8.1M-17.3% | $9.8M+96.0% | ||
| $97K— | —— | —— | —— | $0— | ||
| —— | $3.19M0.0% | $3.19M0.0% | $3.19M0.0% | $3.19M+1,015% | ||
| —— | —— | 17%— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | 0.1%— | —— | —— | —— | ||
| —— | $530.5K0.0% | $530.5K0.0% | $530.5K0.0% | $530.5K— | ||
| $3.55M+256% | -$2.27M— | —— | —— | $0— | ||
| $53K— | —— | —— | —— | $0— | ||
| —— | $12.32M0.0% | $12.32M0.0% | $12.32M0.0% | $12.32M— | ||
| —— | $15.5K0.0% | $15.5K0.0% | $15.5K0.0% | $15.5K+933% | ||
| $41.65M-55.1% | $92.74M+206% | $30.35M+1.3% | $29.97M+51.9% | $19.73M+451% | ||
| $41.65M-55.1% | $92.74M+206% | $30.35M+1.3% | $29.97M+51.9% | $19.73M+451% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does CorMedix generate?
- CorMedix (CRMD) generated $197.7M in operating cash flow over the trailing twelve months.
- What is CorMedix's free cash flow?
- After $3.0M of capital expenditures, CorMedix's free cash flow was $194.7M over the trailing twelve months, up 1528.3% year over year.
- Where does CorMedix's cash flow data come from?
- Every line is extracted from CorMedix's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
